GSK983: A novel compound with broad-spectrum antiviral activity
A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays
Retroviral self-inactivation in the mouse vagina induced by short DNA
Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay
Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006
Replicons from genotype 1b HCV-positive sera exhibit diverse sensitivities to anti-HCV reagents
Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1
Enhanced inhibition of porcine reproductive and respiratory syndrome virus replication by combination of morpholino oligomers
Synonymous mutations in stem-loop III of Rev responsive elements enhance HIV-1 replication impaired by primary mutations for resistance to enfuvirtide
Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection
Development of a cell-based assay for high-throughput screening of inhibitors against HCV genotypes 1a and 1b in a single well
Anti-influenza virus activity and structure–activity relationship of aglycoristocetin derivatives with cyclobutenedione carrying hydrophobic chains